The EU and UK just approved a brain-delivered gene therapy for AADC deficiency, and PTC Therapeutics plans to seek U.S. approval for it this year. Read More
‘There’s a lot of exciting times ahead of us’: Game-changing gene therapy for brain disorders is right around the corner
